xmlns:atom="http://www.w3.org/2005/Atom"

PART 9Borderline products

Effect of final determination

164.—(1) If the licensing authority makes a final determination that a product is a medicinal product, it may give a notice to any person—

(a)who has sold or supplied the product, or has offered to sell or supply it; or

(b)whom the licensing authority thinks may sell or supply the product.

(2) The notice must require the person—

(a)to cease to sell, supply or offer to sell or supply the product from the date specified in the notice until a marketing authorisation, traditional herbal registration, certificate of registration or Article 126a authorisation is granted in respect of the product; or

(b)not to sell, supply or offer to sell or supply the product unless a marketing authorisation, traditional herbal registration, certificate of registration or Article 126a authorisation is granted in respect of the product.